Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
作者： Brian J. Druker , Nicholas B. Lydon
DOI: 10.1172/JCI9083
关键词:
摘要: … Based on its clear disease association, we saw the Bcr-Abl … In solid tumors, blood levels may or may not be predictive of … an inhibitor such that this unintended activity is removed. …
elsevier.com
dm5migu4zj3pb.cloudfront.net 参考文章(28)
Donald B. Kohn, Gerhard Bauer, C. Robert Rice, J.C. Rothschild, Denise A. Carbonaro, Penelope Valdez, Qian-lin Hao, Chen Zhou, Ingrid Bahner, Karen Kearns, Kate Brody, Sarah Fox, Elizabeth Haden, Kathy Wilson, Cathy Salata, Cathy Dolan, Charles Wetter, Estuardo Aguilar-Cordova, Joseph Church, A Clinical Trial of Retroviral-Mediated Transfer of arev-Responsive Element Decoy Gene Into CD34+Cells From the Bone Marrow of Human Immunodeficiency Virus-1–Infected Children Blood. ,vol. 94, pp. 368- 371 ,(1999) , 10.1182/BLOOD.V94.1.368.413A47_368_371
Martin Carroll, Sayuri Ohno-Jones, Shu Tamura, Elisabeth Buchdunger, Jürg Zimmermann, Nicholas B. Lydon, D. Gary Gilliland, Brian J. Druker, CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins Blood. ,vol. 90, pp. 4947- 4952 ,(1997) , 10.1182/BLOOD.V90.12.4947.4947_4947_4952
Michael W.N. Deininger, John M. Goldman, Nicholas Lydon, Junia V. Melo, The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells Blood. ,vol. 90, pp. 3691- 3698 ,(1997) , 10.1182/BLOOD.V90.9.3691
Naomi Rosenberg, Owen N. Witte, The viral and cellular forms of the Abelson (abl) oncogene. Advances in Virus Research. ,vol. 35, pp. 39- 81 ,(1988) , 10.1016/S0065-3527(08)60708-3
Brian J. Druker, Conor Heaney, James D. Griffin, John R. Hagopian, Keiko Okuda, Tsukasa Oda, Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. Journal of Biological Chemistry. ,vol. 269, pp. 22925- 22928 ,(1994) , 10.1016/S0021-9258(17)31596-X
Brian J. Druker, Elisabeth Buchdunger, Thomas Meyer, Marcel Müller, Nicholas B. Lydon, Helmut Mett, Jürg Zimmermann, Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative Cancer Research. ,vol. 56, pp. 100- 104 ,(1996)
S. Clark, J McLaughlin, M Timmons, A. Pendergast, Y Ben-Neriah, L. Dow, W Crist, G Rovera, S. Smith, O. Witte, Expression of a Distinctive BCR-ABL Oncogene in Ph1-positive Acute Lymphocytic Leukemia (ALL) Science. ,vol. 239, pp. 775- 777 ,(1988) , 10.1126/SCIENCE.3422516
Annelies de Klein, Anne Hagemeijer, Ton van Agthoven, Ad Geurts van Kessel, Dirk Bootsma, Gerard Grosveld, Malcolm A. Ferguson-Smith, Teresa Davies, Marion Stone, Nora Heisterkamp, John R. Stephenson, John Groffen , Claus R. Bartram, Translocation of c- abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia Nature. ,vol. 306, pp. 277- 280 ,(1983) , 10.1038/306277A0
JANET D. ROWLEY, Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. ,vol. 243, pp. 290- 293 ,(1973) , 10.1038/243290A0
M. A. Kelliher, J. McLaughlin, O. N. Witte, N. Rosenberg, Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 6649- 6653 ,(1990) , 10.1073/PNAS.87.17.6649